Details
Stereochemistry | ACHIRAL |
Molecular Formula | K |
Molecular Weight | 39.0983 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[K]
InChI
InChIKey=NTTOTNSKUYCDAV-UHFFFAOYSA-N
InChI=1S/K.H
Molecular Formula | K |
Molecular Weight | 39.0983 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Glycosphingolipids modulate renal phosphate transport in potassium deficiency. | 2001 Aug |
|
Functional and molecular characterization of the K-Cl cotransporter of Xenopus laevis oocytes. | 2001 Aug |
|
KT3.2 and KT3.3, two novel human two-pore K(+) channels closely related to TASK-1. | 2001 Jul |
|
Simultaneous side effects of both clozapine and valproate. | 2001 May |
|
Does acetaldehyde mediate ethanol action in the central nervous system? | 2001 Nov |
|
Evidence supporting a role for KCl cotransporter in the thick ascending limb of Henle's loop. | 2001 Nov |
|
The small conductance K+ channel, KCNQ1: expression, function, and subunit composition in murine trachea. | 2001 Nov 9 |
|
IP(3) receptor function and localization in myotubes: an unexplored Ca(2+) signaling pathway in skeletal muscle. | 2001 Oct |
|
Activation of Na+/K+-ATPase by the serum and glucocorticoid-dependent kinase isoforms. | 2002 |
|
Loss-of-function polymorphism of the human kallikrein gene with reduced urinary kallikrein activity. | 2002 Apr |
|
The antidepressant drug fluoxetine is an inhibitor of human ether-a-go-go-related gene (HERG) potassium channels. | 2002 Feb |
|
Cloning of rabbit Kir6.1, SUR2A, and SUR2B: possible candidates for a renal K(ATP) channel. | 2002 Feb |
|
Characterization of basolateral K+ channels underlying anion secretion in the human airway cell line Calu-3. | 2002 Feb 1 |
|
Troglitazone inhibits both post-glutamate neurotoxicity and low-potassium-induced apoptosis in cerebellar granule neurons. | 2002 Jan 11 |
|
Guanylin, uroguanylin, and heat-stable euterotoxin activate guanylate cyclase C and/or a pertussis toxin-sensitive G protein in human proximal tubule cells. | 2002 May 17 |
|
Ammonia prevents glutamate-induced but not low K(+)-induced apoptosis in cerebellar neurons in culture. | 2003 |
|
Inactivation of aconitase during the apoptosis of mouse cerebellar granule neurons induced by a deprivation of membrane depolarization. | 2003 Feb 15 |
|
A novel two-pore domain K+ channel, TRESK, is localized in the spinal cord. | 2003 Jul 25 |
|
Plasticity of KIR channels in human smooth muscle cells from internal thoracic artery. | 2003 Jun |
|
Inhibition of G protein-activated inwardly rectifying K+ channels by fluoxetine (Prozac). | 2003 Mar |
|
Functional identification of ion binding sites at the internal end of the pore in Shaker K+ channels. | 2003 May 15 |
|
Effects of truncated angiotensins in humans after double blockade of the renin system. | 2003 Nov |
|
[Production of aldosterone by rat mesangial cell and the accumulation of extracellular matrix induced by aldosterone]. | 2003 Nov 10 |
|
Classification and rescue of ROMK mutations underlying hyperprostaglandin E syndrome/antenatal Bartter syndrome. | 2003 Sep |
|
The renal-specific transporter mediates facilitative transport of organic anions at the brush border membrane of mouse renal tubules. | 2004 Aug |
|
A thallium-sensitive, fluorescence-based assay for detecting and characterizing potassium channel modulators in mammalian cells. | 2004 Dec |
|
Differential effects of CB1 and opioid agonists on two populations of adult rat dorsal root ganglion neurons. | 2004 Feb 18 |
|
Predictors of in-hospital ventricular fibrillation or torsades de pointes in patients with acute symptomatic bradycardia. | 2004 Jan |
|
4-Chloro-benzo[F]isoquinoline (CBIQ) activates CFTR chloride channels and KCNN4 potassium channels in Calu-3 human airway epithelial cells. | 2004 Jun |
|
Melatonin receptor agonist 2-iodomelatonin prevents apoptosis of cerebellar granule neurons via K(+) current inhibition. | 2004 Mar |
|
A TASK3 channel (KCNK9) mutation in a genetic model of absence epilepsy. | 2005 |
|
Effect of p47phox gene deletion on ROS production and oxygen sensing in mouse carotid body chemoreceptor cells. | 2005 Dec |
|
Fenamates and diltiazem modulate lipid-sensitive mechano-gated 2P domain K(+) channels. | 2005 Dec |
|
Effect of beta-adrenoceptor blockers on human ether-a-go-go-related gene (HERG) potassium channels. | 2005 Feb |
|
Additional repression of activity-dependent c-fos and BDNF mRNA expression by lipophilic compounds accompanying a decrease in Ca2+ influx into neurons. | 2005 Jan |
|
Kir6.2-deficient mice are susceptible to stimulated ANP secretion: K(ATP) channel acts as a negative feedback mechanism? | 2005 Jul 1 |
|
Inhibition of GSK3beta is a common event in neuroprotection by different survival factors. | 2005 Jun 13 |
|
Interaction of acetylcholine with Kir6.1 channels heterologously expressed in human embryonic kidney cells. | 2005 May 16 |
|
Monovalent cation leaks in human red cells caused by single amino-acid substitutions in the transport domain of the band 3 chloride-bicarbonate exchanger, AE1. | 2005 Nov |
|
Functional expression of Kir2.x in human aortic endothelial cells: the dominant role of Kir2.2. | 2005 Nov |
|
TASK-like K+ channels mediate effects of 5-HT and extracellular pH in rat dorsal vagal neurones in vitro. | 2005 Oct 1 |
|
Erectile dysfunction in mice lacking the large-conductance calcium-activated potassium (BK) channel. | 2005 Sep 1 |
|
Histamine excites neonatal rat sympathetic preganglionic neurons in vitro via activation of H1 receptors. | 2006 Apr |
|
Activation and enzymatic characterization of recombinant human kallikrein 8. | 2006 Jun |
|
Functional expression of the TRPM4 cationic current in ventricular cardiomyocytes from spontaneously hypertensive rats. | 2006 Oct |
|
Adaptive downregulation of a quinidine-sensitive cation conductance in renal principal cells of TWIK-1 knockout mice. | 2006 Oct |
|
The effect of high extracellular potassium on IKr inhibition by anti-arrhythmic agents. | 2007 |
|
TGF-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis. | 2007 Feb |
|
TRPM4, a Ca2+-activated nonselective cation channel in mouse sino-atrial node cells. | 2007 Feb 1 |
|
Testosterone and progesterone rapidly attenuate plasma membrane Gbetagamma-mediated signaling in Xenopus laevis oocytes by signaling through classical steroid receptors. | 2007 Jan |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 19:47:21 GMT 2023
by
admin
on
Fri Dec 15 19:47:21 GMT 2023
|
Record UNII |
RWP5GA015D
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
CFR |
21 CFR 176.170
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
WHO-VATC |
QC03AB03
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
WHO-VATC |
QC03AB09
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
42569-4
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
2825-8
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
WHO-ATC |
C03CB02
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
WHO-ATC |
C03AB05
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
WHO-VATC |
QA12BA03
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
WHO-VATC |
QA12BA04
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
WHO-ATC |
C03EA14
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
75940-7
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
32336-0
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
77142-8
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
21476-7
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
25506-7
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
WHO-VATC |
QC03AB05
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
57380-8
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
56143-1
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
49789-1
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
18372-3
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
WHO-ATC |
R05CA02
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
2821-7
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
5927-9
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
WHO-VATC |
QC03AB08
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
6940-1
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
79710-0
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
WHO-ATC |
C03CB01
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
50902-6
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
2824-1
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
22760-3
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
2958-7
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
2959-5
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
14172-1
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
28003-2
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
WHO-ATC |
C03EA04
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
WHO-ATC |
C03BB07
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
WHO-ATC |
C03AB04
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
CFR |
21 CFR 862.1600
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
6792-6
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
39785-1
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
WHO-ATC |
C03AB07
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
WHO-VATC |
QC03AB01
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
WHO-ATC |
C03AB08
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
58996-0
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
41656-0
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
82722-0
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
WHO-VATC |
QC03AB06
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
11148-4
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
13798-4
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
2820-9
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
39790-1
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
2822-5
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
12814-0
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
WHO-VATC |
QC03AB02
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
59162-8
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
30549-0
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
87455-2
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
49788-3
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
NCI_THESAURUS |
C1940
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
DSLD |
106 (Number of products:9399)
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
WHO-ATC |
C03AB01
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
27441-5
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
WHO-VATC |
QC03BB04
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
17795-6
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
57355-0
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
87454-5
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
35677-4
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
32550-6
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
WHO-VATC |
QC03BB07
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
43222-9
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
44406-7
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
6298-4
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
56971-5
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
51720-1
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
WHO-ATC |
C03BB05
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
WHO-ATC |
C03AB09
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
WHO-ATC |
V03AB21
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
2823-3
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
WHO-VATC |
QC03CB02
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
53123-6
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
WHO-ATC |
C03AB03
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
WHO-VATC |
QC03AB04
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
57379-0
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
2819-1
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
WHO-VATC |
QC03BB05
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
2826-6
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
60218-5
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
WHO-VATC |
QC03BB03
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
WHO-ATC |
C03AB02
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
9482-1
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
39789-3
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
WHO-ATC |
C03AB06
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
WHO-ATC |
A12BA01
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
WHO-ATC |
C03BB03
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
15202-5
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
WHO-ATC |
C03BB04
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
WHO-VATC |
QC03BB02
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
WHO-VATC |
QC03CB01
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
2829-0
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
WHO-ATC |
S01XA04
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
WHO-ATC |
C03BB02
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
32713-0
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
2828-2
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
WHO-VATC |
QC03AB07
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
||
|
LOINC |
33949-9
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
Potassium
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
PRIMARY | |||
|
5462222
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
PRIMARY | |||
|
7440-09-7
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
PRIMARY | |||
|
SUB14961MIG
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
PRIMARY | |||
|
RWP5GA015D
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
PRIMARY | |||
|
DB01345
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
PRIMARY | |||
|
26216
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
PRIMARY | |||
|
m8995
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
PRIMARY | Merck Index | ||
|
100000091749
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
PRIMARY | |||
|
D011188
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
PRIMARY | |||
|
231-119-8
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
PRIMARY | |||
|
RWP5GA015D
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
PRIMARY | |||
|
DTXSID9049748
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
PRIMARY | |||
|
8588
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
PRIMARY | RxNorm | ||
|
C765
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
PRIMARY | |||
|
698
Created by
admin on Fri Dec 15 19:47:21 GMT 2023 , Edited by admin on Fri Dec 15 19:47:21 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
Nutritional value per 100 g (3.5 oz) - 316 mg (7%)
|